Firma TissUse, Autor bei Presse-Blog

New Multi-Organ-Chip project towards vaccine & drug candidate testing for Tuberculosis

7. November 20227. November 2022 Firma TissUseBiotechnikbiotechnology, BMGF, Collaboration, disease model, humimic, mps, Multi-Organ-Chip, Organ-on-a-Chip, research, tissuse, tuberculosis, vaccines

TissUse will receive funding from the Bill & Melinda Gates Foundation to develop a human preclinical lung-liver-lymph node co-culture on a HUMIMIC Chip infectable with Mycobacterium tuberculosis. This collaboration will contribute to the development of Tuberculosis vaccine candidates and treatment. Mehr

Philip Morris International and TissUse develop a human aerosol test platform to emulate the entire human respiratory tract

21. Juni 202121. Juni 2021 Firma TissUseForschung und Entwicklungbone, bronchial, cell, dosing, hair, humimic, inhalable, liver, nicotine, skin, smoke, stopped, thyroid, tissuse, with

PMI and TissUse have signed a collaboration agreement to utilize PMI’s InHALES technology in combination with TissUse’s proprietary Multi-Organ-Chip (MOC) platform to enable inhalation exposure of functional human tissues in homeostasis at minute scale in vitro. The two partners will Mehr

TissUse GmbH appoints Dr. Reyk Horland as new CEO while TissUse’s founder

1. Oktober 2020 Firma TissUseFirmeninternblood, company, energy, humimic, immune, market, network, new, pharmaceutical, platform, research, strong, technology, tissuse, with

On its 10th company anniversary, TissUse GmbH appoints Dr. Reyk Horland, previously VP Business Development, as the new CEO. Reyk Horland has been with TissUse since it was founded in 2010 and has implemented a profitable product business with a Mehr

TissUse has been certified under the ISO EN 9001-2015

12. Dezember 201912. Dezember 2019 Firma TissUseForschung und Entwicklungchip, company, dekra, document, iso, management, marx, process, quality, services, systems?, technology, testing, tissuse, with

TissUse – the leading pioneer of the Multi-Organ-Chips technology enabling highly predictive substance testing has been awarded the ISO EN 9001-2015. The ISO 9001-2015 is a globally recognized standard that certifies quality management systems focused on ongoing improvements, customer satisfaction and implementing Mehr

TissUse Launches New Product Brand HUMIMIC

3. Juni 201911. Dezember 2019 Firma TissUseForschung und Entwicklungautoplant, berlin, company, cosmetic, customers, device, devices, humimic, new, pharmaceutical, solutions, systems?, technology, tissuse, with

TissUse, the Berlin-based pioneers in Human-on-a-Chip developments, have launched their new product brand HUMIMIC. From now on, all of the company’s products will be marketed under this common brand. As a result, TissUse GmbH’s products will have a uniform name Mehr

TissUse launcht neue Produktmarkte HUMIMIC

3. Juni 201911. Dezember 2019 Firma TissUseForschung und Entwicklungautomaten, autoplant, berliner, brand, chip, chip4, Chips, geräte, kunden, marx, mitarbeiter, starter, Technologie, tissuse, unternehmen

TissUse, die Berliner Pioniere in Human-on-a-Chip Entwicklungen haben Ihre Produktmarke HUMIMIC gelauncht. Unter diesem Brand werden in Zukunft alle Produkte des Unternehmens gebündelt. Unter der Marke HUMIMIC bekommen die Produkte der TissUse GmbH ab sofort einen einheitlichen Auftritt und eine Mehr

TissUse grants first Smart Hair Transplant (SHT) License in Japan

8. April 201911. Dezember 2019 Firma TissUseForschung und Entwicklungcell, devices, financial, hair, hewitt, medical, prp, sht, smart, technology, therapy, tissuse, transplant, with, wrinkle

For the first time, TissUse has granted development and distribution rights of its existing Smart Hair Transplant (SHT) technology to J. Hewitt, a Japan-based biopharmaceutical company focused on creating transformative regenerative medicine for aesthetic surgery. Under the terms of this Mehr

TissUse establishes a liver-endocrine tissues multi-organ model for risk assessment with Bayer

3. September 201811. Dezember 2019 Firma TissUseForschung und Entwicklungbayer, bone, cardiac, cartilage, cells, fatty, hair, kidney, liver, new, power, skin, thyroid, tissuse, with

TissUse has signed a collaboration agreement with Bayer to develop a highly innovative liver-endocrine tissues assay using TissUse’s Multi-Organ-Chip (MOC) technology. Under the terms of the collaboration agreement, TissUse will join forces with Bayer to develop a novel mechanistic in Mehr

TissUse announces new partnership with leading pharmaceutical company to develop applications for its Multi-Organ-Chip platform in drug research and development

5. März 201811. Dezember 2019 Firma TissUseMedizintechnikantibodies, antibody, aspect, cardiac, cartilage, cell, cells, dosing, hair, kidney, liver, roche, skin, tissuse, with

TissUse and Roche have signed a cooperating agreement to develop human-relevant in vitro assays based on TissUse’s Multi-Organ-Chip technology. Under the terms of the collaboration agreement, TissUse will provide its Multi-Organ-Chip (MOC) technology as a highly versatile tool to develop Mehr

TissUse reports progress made in collaboration with AstraZeneca to use Microphysiological Systems in the drug development process

22. Januar 201811. Dezember 2019 Firma TissUseForschung und EntwicklungBiotech, cell, chemicals, danielson, diabetes, disease, imed, insulin, mps, new, patients, study, testing, tissuse, with

TissUse continues their successful collaboration with AstraZeneca to establish relevant Microphysiological System (MPS) models based on TissUse’s Multi-Organ-Chip technology. As part of the collaboration, the teams have explored the unmet need for a physiologically relevant human ex-vivo type 2 diabetes Mehr

Autor: Firma TissUse